Functional Foods, Nutraceuticals, and Disease Prevention: A Window to the Future of Health Promotion

Author(s):  
Gopinadhan Paliyath ◽  
Kalidas Shetty
2021 ◽  
pp. 121-138
Author(s):  
Christopher Dye

Consumers are ultimately responsible for ‘behavioural’ risks to their health, but the behaviours in question are also those of manufacturers and governments, and the burden of choice on consumers is lighter when shared. Governments, in particular, have the motives, means, and powers to intervene between commercial supply and consumer demand. Among the most effective instruments of government are taxation and regulation, especially for the control of single, major causes of illness such as tobacco and sugar. Taxes put a value on the future, today: consumers and manufacturers can choose to pay immediately for the costs incurred to society in future, or switch to healthier lifestyles and business practices. In practice, governments under pressure from lobbyists tend to under-tax harmful commodities, so other enticements are needed too. In this context, empirical studies show health promotion is complementary to disease prevention—making health gains while avoiding health losses—especially when the joint benefits for health are large.


Foods ◽  
2020 ◽  
Vol 9 (8) ◽  
pp. 1100
Author(s):  
Francesco Donsì ◽  
Giovanna Ferrari

In modern foods, the delivery systems for bioactive compounds play a fundamental role in health promotion, wellbeing, and disease prevention through diet. Nanotechnology has secured a fundamental role in the fabrication of delivery systems with the capability of modulating the in-product and in-body behavior for augmenting bioavailability and activity of bioactive compounds. Structured nanoemulsions and nanoparticles, liposomes, and niosomes can be designed to improve bioactives preservation after ingestion, mucoadhesion, as well as of their release and pathophysiological relevance. In the future, it is expected that the delivery systems will also contribute to augment the efficacy of the bioactive compounds, for example by improving the intestinal absorption and delivery in the bloodstream, as well as promoting the formation of additional bioactive metabolites by regulating the transformations taking place during digestion and the interaction with the intestinal microbiota.


2011 ◽  
Author(s):  
Shava Cureton ◽  
LaShawn Hoffman ◽  
David Collins ◽  
Lisa M. Goodin ◽  
Elizabeth Armstrong-Mensah

Sign in / Sign up

Export Citation Format

Share Document